Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors

Diagnostic Assessment Study, Single Site and Prospective, comparing18F-DOPA PET and Multiparametric RMI in Initial Exploration of Diffuse Glial Tumors

For patient having a brain tumor, RMI is the standard exam for tumor characterization and determines initial surgery.

The aim of this study is to assess if PET could provide additional information that could have an impact on surgery (indication and planification)

Inclusion Criteria:

• Suspected glial resectable tumor
• Free and informed consent
• Affiliated to French social security

Exclusion Criteria:

• Suspected high grade glioma
• Surgical emergency
• Pregnant or breastfeeding woman
• Patient deprived of their liberty or under guardianship
• Patient not able to follow study medical monitoring for geographical, social or psychological reasons
• Treated with carbidopa, catechol-O-methyl transferase inhibitor, haloperidol, reserpine within 2 weeks before PET imagery